Alkem Laboratories Ltd - 539523 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Please find enclosed herewith the details regarding the voting results of the business transacted through Postal Ballot by remote e-voting process in the prescribed format alongwith the Scrutinizer''s Report. Alkem Laboratories Ltd - 539523 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Please find attached herewith the details regarding the voting results of the business transacted through Postal Ballot by remote e-voting process in the prescribed format alongwith the Scrutinizers Report. Alkem Laboratories Ltd - 539523 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prasann Kumar Kedia Alkem Laboratories Ltd - 539523 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015- Incorporation Of A Wholly Owned Subsidiary Of The Company
Pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a Wholly Owned Subsidiary of the Company in the name of ''Alkem Medtech Private Limited'' has been incorporated on 27th March, 2024.
Alkem Laboratories sinks 3 percent on US FDA's 10 observations for Himachal unit
After the US FDA inspection, Alkem Laboratories has received Form 483 with 10 observations for its Baddi plant. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
This is to inform you that USFDA had conducted an inspection at the Company''s manufacturing facility located at Baddi from 19th March, 2024 to 27th March, 2024. At the end of the inspection, the Company has received Form 483 with 10 observations. This was a GMP as well as a Pre-Approval inspection. There is no data integrity observation. Alkem Laboratories Ltd - 539523 - Closure of Trading Window
This is to inform you that the trading window will remain closed from 30th March, 2024 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter and year ended 31st March, 2024 are communicated to the Stock Exchanges. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith are the details of Analyst/ Institutional Investor meetings to be conducted. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find enclosed the details of investor meet scheduled on 20th March, 2024. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith are the details of Analyst/ Institutional Investor/ Broker meetings to be conducted.